Cognition Therapeutics (CGTX) Enterprise Value (2020 - 2026)
Cognition Therapeutics (CGTX) reported Enterprise Value of -$31.1 million for Q1 2026, down 89.49% year-over-year from -$296.3 million in Q1 2025, and up 15.43% on a QoQ basis from -$36.8 million in Q4 2025.
Cognition Therapeutics (CGTX) has 7 years of Enterprise Value data on file, last reported at -$31.1 million in Q1 2026.
- Quarterly Enterprise Value fell 89.49% year-over-year to -$31.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$31.1 million (down 89.49% YoY) and the FY2025 annual result came in at -$36.8 million, down 47.19% from the prior year.
- Enterprise Value climbed to -$31.1 million in Q1 2026 per CGTX's latest filing, from -$36.8 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$10.7 million in Q2 2025 and bottomed at -$51.5 million in Q1 2022.
- The 5-year median for Enterprise Value is -$34.7 million (2024), against an average of -$33.5 million.
- The widest annual swing landed in 2022, when Enterprise Value slumped 461.57%; it then jumped 62.35% in 2025.
- Tracing CGTX's Enterprise Value over 5 years: stood at -$41.6 million in 2022, then climbed by 28.01% to -$29.9 million in 2023, then increased by 16.42% to -$25.0 million in 2024, then tumbled by 47.19% to -$36.8 million in 2025, then advanced by 15.43% to -$31.1 million in 2026.
- Per Business Quant, the three latest CGTX Enterprise Value figures stand at -$31.1 million (Q1 2026), -$36.8 million (Q4 2025), and -$39.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | -901.90 Mn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | -8.75 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | -18.44 Mn |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Cognition Therapeutics | 648,270.00 | 648,270.00 | - | -31.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31.13 Mn |
| Dec 31, 2025 | -36.81 Mn |
| Sep 30, 2025 | -39.33 Mn |
| Jun 30, 2025 | -10.74 Mn |
| Mar 31, 2025 | -16.43 Mn |
| Dec 31, 2024 | -25.01 Mn |
| Sep 30, 2024 | -22.01 Mn |
| Jun 30, 2024 | -28.53 Mn |
| Mar 31, 2024 | -34.67 Mn |
| Dec 31, 2023 | -29.92 Mn |
| Sep 30, 2023 | -32.97 Mn |
| Jun 30, 2023 | -37.19 Mn |
| Mar 31, 2023 | -38.81 Mn |
| Dec 31, 2022 | -41.56 Mn |
| Sep 30, 2022 | -46.61 Mn |
| Jun 30, 2022 | -45.77 Mn |
| Mar 31, 2022 | -51.51 Mn |
| Dec 31, 2021 | -54.72 Mn |
| Sep 30, 2021 | -8.30 Mn |
| Dec 31, 2020 | -5.19 Mn |